https://staging.captis.com/wp-content/uploads/2021/03/medicine-257349_1280.jpg8471280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-03-04 00:50:062021-03-04 02:26:32Takeda secures global rights to develop and commercialise soticlestat
https://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.png00CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-03-03 04:44:262021-03-03 05:29:59Merck enters multiple agreements for supply of Covid-19 medicines and vaccines
https://staging.captis.com/wp-content/uploads/2021/03/PBR-1.jpg9321280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-03-02 00:52:352021-03-02 01:21:41Boehringer Ingelheim, Gubra to validate new Peptides for obesity
https://staging.captis.com/wp-content/uploads/2021/02/PBR-2-3.jpg8541280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-25 08:09:412021-03-01 09:00:41Moderna to boost global Covid-19 vaccine manufacturing capacity
https://staging.captis.com/wp-content/uploads/2021/02/PBR-1-2.jpg8001280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-25 02:22:222021-02-25 04:01:33ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults
https://staging.captis.com/wp-content/uploads/2021/02/PBR-2-2.jpg8531280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-02-24 08:02:052021-02-24 08:28:52UCB expands partnership with Microsoft to speed up drug development